EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020–2023

Laïyna Lilo Aouichi, Elise Pape, Jean-Yves Jouzeau, Valérie Gibaja, Eyrian Aubin-Beale, Allan Kolodziej, Catherine Feliu, Elodie Marchand, Nicolas Gambier, Julien Scala-Bertola iD

Fundamental & Clinical Pharmacology · 2025

DOI: 10.1111/fcp.13060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2025. Verfasst von Laïyna Lilo Aouichi und 9 weiteren Autor:innen. Beteiligte Einrichtung: CHRU-Nancy, Service de Pharmacologie Clinique et Toxicologie, Université de Lorraine, Nancy, France. Hauptthemen laut MEDLINE: Ketamine, Saliva, Substance Abuse Detection, Driving Under the Influence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Ketamine is a psychoactive substance used for its stimulant and hallucinogenic properties. As the use of ketamine may lead to impaired driving, we aimed to assess the occurrence of ketamine in the driving population tested positive for narcotics in roadside checks using oral fluid analysis. Oral fluid concentrations of ketamine and norketamine were examined to determine the percentage of drivers susceptible to ketamine impairment.

Methods

A retrospective descriptive study was conducted over a 32‐month period in 2020–2023 on drivers who tested positive to the DrugWipe®5S saliva test in our region of northeastern France. Mass spectrometry was used to confirm the DrugWipe®5S result and to determine oral fluid concentrations of ketamine and norketamine.

Results

During the entire study period, 3364 drivers were tested positive at the roadside using the DrugWipe®5S rapid test. After mass spectrometry, 3043 drivers were finally confirmed as true positives. Ketamine was detected in 88 drivers who were 80.7% male, 95.4% polydrug users and were 27.5 ± 7.1 years old, representing 2.6% of the total driver population. Ketamine concentrations were 821 ± 2264 and 7.8 ± 12.3 ng/mL in the presence and absence of norketamine, respectively. Finally, 26.1% of the ketamine‐positive drivers had a ketamine oral fluid concentration potentially associated with impaired driving.

Conclusion

Ketamine and norketamine should be added to the list of drugs to be tested in oral fluid for driving under the influence of drugs. Besides blood or urine, oral fluid could be an interesting alternative biological matrix for addiction medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineSalivaSubstance Abuse DetectionDriving Under the InfluenceAutomobile DrivingHumansMaleFranceRetrospective StudiesFemaleAdultYoung AdultMiddle AgedSubstance-Related DisordersMass Spectrometry

Stichwörter der Autor:innen

addictiondrug abusedrug testingketamineoral fluid

Substanzen

Ketaminenorketamine

Autor:innen und Institutionen

  • CHRU-Nancy, Service de Pharmacologie Clinique et Toxicologie, Université de Lorraine, Nancy, France.
  • CNRS, IMoPA, Université de Lorraine, Nancy, France.
  • CHRU Nancy, CEIP-Addictovigilance, Université de Lorraine, Nancy, France.
  • CHU Reims, Laboratoire de pharmacologie, Université de Reims Champagne Ardenne, Reims, France.
  • PPF UR3801 Pharmacologie et Pathologies fragilisantes, Université de Reims Champagne Ardenne, Reims, France.
  • CHRU Nancy, Department of Legal Medicine, Université de Lorraine, Nancy, France.

ORCID-Profile: Julien Scala-Bertola

Zitieren

APA

Aouichi, L. L., Pape, E., Jouzeau, J. Y., Gibaja, V., Aubin-Beale, E., Kolodziej, A., Feliu, C., Marchand, E., Gambier, N., & Scala-Bertola, J. (2025). Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020–2023. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.13060

Vancouver

Aouichi LL, Pape E, Jouzeau JY, Gibaja V, Aubin-Beale E, Kolodziej A, et al. Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020–2023. Fundamental & Clinical Pharmacology. 2025. doi:10.1111/fcp.13060

BibTeX
@article{Aouichi2025,
  author = {Aouichi, Laïyna Lilo and Pape, Elise and Jouzeau, Jean-Yves and Gibaja, Valérie and Aubin-Beale, Eyrian and Kolodziej, Allan and Feliu, Catherine and Marchand, Elodie and Gambier, Nicolas and Scala-Bertola, Julien},
  title = {Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020–2023},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2025},
  doi = {10.1111/fcp.13060}
}
Kostenlos starten →